$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

루이소체 치매로 추정되는 이차성 파킨슨증 환자의 Non-Motor Symptom Scale(NMSS)로 평가한 비운동성 증상을 한약과 침의 복합치료로 호전시킨 증례보고 1례
A Case Report of Non-Motor Symptoms Evaluated Using the Non-Motor Symptom Scale in a Patient with Secondary Parkinsonism Presumed to be Probable Lewy Body Dementia and Improved with Combined Treatment with Herbal Medicine and Acupuncture 원문보기

대한한방내과학회지 = The journal of internal Korean medicine, v.42 no.5, 2021년, pp.833 - 845  

노민영 (목동동신한방병원 한방내과) ,  이지현 (목동동신한방병원 한방내과) ,  한양희 (목동동신한방병원 한방내과) ,  임정태 (원광대학교 전통의학연구소)

Abstract AI-Helper 아이콘AI-Helper

Parkinson's syndrome is a degenerative brain disease that presents characteristic motor symptoms of tremor, rigidity, and gait disturbance. In addition to these motor symptoms, Parkinson's syndrome also presents non-motor symptoms (NMSs) such as sleep disturbance and cognitive decline. NMSs reduce p...

주제어

표/그림 (7)

참고문헌 (38)

  1. Nocera J, Horvat M, Ray CT. Effects of home-based exercise on postural control and sensory organization in individuals with Parkinson disease. Parkinsonism Relat Disord 2009;15(10):742-5. 

  2. Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, et al. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol 2015;22(1):37-43. 

  3. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009;73(19):1584-91. 

  4. Park YC, Chang DI, Lee YH, Park DS. The study on the effect of acupuncture treatment in patients with idiopathic Parkinson's disease. J Acupunct Res 2007;24(4):43-54. 

  5. Mueller C, Ballard C, Corbett A, Aarsland D. The prognosis of dementia with Lewy bodies. Lancet Neurol 2017;16(5):390-8. 

  6. Zaccai J, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 2005;34(6):561-6. 

  7. Kim TH. Diagnosis and Management of Dementia with Lewy Bodies. J Korean Geriatr Psychiatry 2012;16(2):75-81. 

  8. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47(5):1113-24. 

  9. Barone P, Antonini A, Colosimo C, Maconi R, Morgante L, Abarello TP, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord Off J Mov Disord Soc 2009;24(11):1641-9. 

  10. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, Group NV. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 2011;26(3):399-406. 

  11. Sohn BK, Lee DW. New Diagnostic Criteria and Treatment for Dementia with Lewy Bodies. J Korean Geriatr Psychiatry 2020;24(2):60-8. 

  12. Subramanian I. Complementary and alternative medicine and exercise in nonmotor symptoms of Parkinson's disease. Int Rev Neurobiol 2017;134:1163-88. 

  13. Koh YM, Kwak JY, Park JH, Ahn TW. 6 Case Reports on Parkinson's Disease Patients Treated by Sasang Constitutional Medicine: Focused on Stance and Gait Analysis. J Sasang Const Med 2017;29(2):182-201. 

  14. Choi IW, Yang JH, Chae IC, Kim CY, Ryu JY, Jung ES, et al. A Case Report of Gait Disturbance in a Patient with Idiopathic Normal Pressure Hydrocephalus Induced by Secondary Parkinsonism Treated with Korean Medicine. J Intern Korean Med 2020;41(5):811-20. 

  15. Roh MY, Jang SW, Kim HH, Han YH, Leem JT. Drug-Induced Dyskinesia Outpatient Suspected to be Induced by Risperidone Management with Yigan-san with Citri Pericarpium and Pinelliae Rhizoma (modified Yigan-san, Yokukan-san Kachimpihang), Electro-Acupuncture at GB34 (陽陵泉), and Stopping Suspected Medication: A Case Report. J Int Korean Med 2019;40(6):1303-10. 

  16. Jeong HS, Kim HR, Kim SY, Yim TB, Jin C, Kwon SW, et al. Effects of Korean Medicine on Pain in Patients with Parkinson's Disease: A Retrospective Study. J Intern Korean Med 2020;41(6):947-58. 

  17. Lee SJ, Ha JB, Lew JH. A Case Study of Parkinson's Disease Patient with Anorexia and Nausea Treated with Korean-medicine Treatment including Hyangsayukgunja-tang. J Intern Korean Med 2020;41(5):717-23. 

  18. Lee SC, Jeong DS, Yang KI, Park HK, Oh HG. Delayed Hemichorea Syndrome Associated with Nonketotic Hyperglycemia. Soonchunhyang Med Sci 2016;22(2):215-7. 

  19. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Boxer AL, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;80(5):496-503. 

  20. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71(9):670-6. 

  21. Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 2017;32(6):853-64. 

  22. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017;89(1):88-100. 

  23. Koh SB, Kim JW, Ma HI, Ahn TB, Cho JW, Lee PH, et al. Validation of the Korean-version of the nonmotor symptoms scale for Parkinson's disease. J Clin Neurol 2012;8(4):276-83. 

  24. Fahn S, Elton RL, UPDRS Program Members. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson's disease, Vol. 2. Florham Park, NJ: Macmillan Healthcare Information; 1987, p. 153-63, 293-304. 

  25. Hahn HM, Yum TH, Shin YW, Kim KH, Yoon DJ, Chung KJ. A Standardization Study of Beck Depression Inventory in Korea. J Korean Neuropsychiatr Assoc 1986;25(3):487-502. 

  26. Colosimo C, Morgante L, Antonini A, Barone P, Avareello TP, Bottacchi E, et al. Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 2010;257(1):5-14. 

  27. Jang JH, Jung KS, Kim JS, Jung IC, Yoo HR, Moon CJ. Potential application of Yokukansan as a remedy for Parkinson's Disease. Evid Based Complement Alternat Med 2018;2018. e1875928. https://doi.org/10.1155/2018/1875928 

  28. Kawanabe T, Yoritaka A, Shimura H, Oizumi H, Tanaka S, Hattori N. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia. Prog Neuropsychopharmacol Biol Psychiatry 2010;34(2):284-7. 

  29. Lee SH, Shin SW, Kim TH, Kim SM, Do TY, Park SG, et al. Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial. Trials 2019;20(1):1-11. 

  30. Lee YS, Kim HC, Whang EH, Jo SK, Lim IG, Han JH. Study on the effect of Jakyakgamcho-tang. J Physiol Pathol Korean Med 2003;17(2):493-8. 

  31. Kim BW. Anti-inflammatory effect of Jakyakgamcho-tang. J Intern Korean Med 2010;31(2):365-71. 

  32. Sung YY, Yuk HJ, Kim DS. Comparison of ingredient quantities and anti-fatigue effects of Jakyakgamcho-Tang according to extraction solvent. Korea J Herbol 2020;35(2):31-8. 

  33. Kim KS, Kim WC, Kim KO. A Study about trends of using Shihogayonggolmoryo-tang granule. Herb Formula Sci 2012;20(1):159-66. 

  34. Lim JS, Leem KH, Kim TY. Sleep-promoting and Anti-anxiety Effects of Shihogayonggolmoryo-tang in Mice. J Physiol Pathol Korean Med 2021;35(1):8-14. 

  35. Kim SN, Doo AR, Park JY, Bae H, Chae Y, Shim IS, et al. Acupuncture Enhances the Synaptic Dopamine Availability to Improve Motor Function in a Mouse Model of Parkinson's Disease. PLoS ONE 6(11):e27566. doi:10.1371/journal.pone.0027566 

  36. Kim JI, Yang EJ, Lee MS, Kim YS, Huh YB, Cho IH, et al. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson's disease. Int J Neurosci 2011;121(4):209-17. 

  37. Doo AR, Kim ST, Kim SN, Moon WJ, Yin CS, Chae YB, et al. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse model of Parkinson's disease. Neurol Res 2010;32(sup1):88-91. 

  38. Cho SY, Lee YE, Doo KH, Lee JH, Jung WS, Moon SK, et al. Efficacy of combined treatment with acupuncture and bee venom acupuncture as an adjunctive treatment for Parkinson's disease. J Altern Complement Med 2018;24(1):25-32. 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로